As of 2026-01-02, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is (2.14) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 5.22 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is -140.9%.
The range of the Relative Valuation is (8.23) - 9.11 EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 9.6x | 7.4x |
| Forward P/E multiples | 6.6x - 9.3x | 7.4x |
| Fair Price | (8.23) - 9.11 | (2.14) |
| Upside | -257.6% - 74.4% | -140.9% |
| Date | P/E |
| 2025-12-31 | -3.30 |
| 2025-12-30 | -3.35 |
| 2025-12-29 | -3.29 |
| 2025-12-24 | -3.16 |
| 2025-12-23 | -3.19 |
| 2025-12-22 | -3.15 |
| 2025-12-19 | -3.15 |
| 2025-12-18 | -3.16 |
| 2025-12-17 | -3.06 |
| 2025-12-16 | -3.05 |
| 2025-12-15 | -3.12 |
| 2025-12-12 | -3.19 |
| 2025-12-11 | -3.19 |
| 2025-12-10 | -3.21 |
| 2025-12-09 | -3.07 |
| 2025-12-08 | -3.08 |
| 2025-12-05 | -3.22 |
| 2025-12-04 | -3.21 |
| 2025-12-03 | -3.32 |
| 2025-12-02 | -3.36 |
| 2025-12-01 | -3.39 |
| 2025-11-28 | -3.42 |
| 2025-11-27 | -3.44 |
| 2025-11-26 | -3.40 |
| 2025-11-25 | -3.41 |
| 2025-11-24 | -3.39 |
| 2025-11-21 | -3.44 |
| 2025-11-20 | -3.47 |
| 2025-11-19 | -3.49 |
| 2025-11-18 | -3.47 |
| 2025-11-17 | -3.66 |
| 2025-11-14 | -3.59 |
| 2025-11-13 | -3.62 |
| 2025-11-12 | -3.66 |
| 2025-11-11 | -3.64 |
| 2025-11-10 | -3.66 |
| 2025-11-07 | -3.42 |
| 2025-11-06 | -3.44 |
| 2025-11-05 | -3.51 |
| 2025-11-04 | -3.68 |
| 2025-11-03 | -3.66 |
| 2025-10-31 | -3.80 |
| 2025-10-30 | -3.87 |
| 2025-10-29 | -3.79 |
| 2025-10-28 | -3.77 |
| 2025-10-27 | -3.84 |
| 2025-10-24 | -3.97 |
| 2025-10-23 | -3.85 |
| 2025-10-22 | -3.92 |
| 2025-10-21 | -4.02 |